The George Institute for Global Health
The George Institute for Global Health
Sydney, New South Wales, Australia1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy | COVID-19, Coronaviridae Infections, Hemic and Lymphatic Diseases, Infections, Neoplasms by Histologic Type, Neurologic Manifestations, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Signs and Symptoms, follicular lymphoma, immune system disorder, immunoproliferative disorder, lung disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, nervous system disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 3 | 2025-04-10 | NCT04904536 |